Skip to content
value.today

ChanRx Corp.

Total raised
$22 M
3 rounds on record
Latest round
$17 M
Feb 2015
First round on record
Nov 2011
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of ChanRx Corp.
MonthRaisedRaiseSizeInvestorsSoldFiling
Feb 2015$17 MNo. 3$10 to $50 million

ChanRx Corp.: Raise no. 3, Feb 2015

Investors in this round

18 investors had bought by the notice of Feb 17, 2015: 18 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$17 M of $32 M offered; $15 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Howard Dittrich · Executive Officer
  • Robert Baltera, Jr. · Executive Officer, Director
  • James Topper · Director
  • Jerel Davis · Director
  • Kevin Lalande · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Robert Baltera, Jr., Chief Executive Officer. Source: SEC Form D, newest notice filed Feb 17, 2015. Read the notice at the SEC.

equitySEC
May 2014$1 MNo. 2Under $2 million

ChanRx Corp.: Raise no. 2, May 2014

Investors in this round

7 investors had bought by the notice of Jun 12, 2014: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $1 M offered
Smallest investment taken
$3,499
What was sold
options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Arthur Brown · Executive Officer, Director
  • Howard Dittrich · Executive Officer
  • Rajesh Khosla · Executive Officer, Director
  • Jim Graham · Director
  • Kevin Lalande · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Rajesh Khosla, Chief Executive Officer. Source: SEC Form D, newest notice filed Jun 12, 2014. Read the notice at the SEC.

optionsSEC
Nov 2011$4 MNo. 1$2 to $10 million

ChanRx Corp.: Raise no. 1, Nov 2011

Investors in this round

8 investors had bought by the notice of Jul 30, 2015: 8 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $5 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Brian Farmer · Executive Officer
  • Howard Dittrich · Executive Officer
  • Robert Baltera, Jr. · Executive Officer, Director
  • James Topper · Director
  • Jerel Davis · Director
  • Kevin Lalande · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Robert Baltera, Jr., Chief Executive Officer. Source: SEC Form D, newest notice filed Jul 30, 2015. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • ChanRx Corp. chose not to state its revenue in its newest notice of a funding round (Jul 2015).

    SEC Form D · Jul 2015

  • The industry group it chose in its notices: Pharmaceuticals.

    SEC Form D · Feb 2015

That is all the official record says: ChanRx Corp. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of ChanRx Corp. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 18 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by ChanRx Corp.
NameRoleNamed in
Brian FarmerExecutive officerJul 2015
Howard DittrichExecutive officerJul 2015
Robert Baltera, Jr.Executive officerJul 2015
Arthur BrownExecutive officerJun 2014
Rajesh KhoslaExecutive officerJun 2014
James TopperDirectorJul 2015
Jerel DavisDirectorJul 2015
Kevin LalandeDirectorJul 2015
Robert Baltera, Jr.DirectorJul 2015
Arthur BrownDirectorJun 2014
Jim GrahamDirectorJun 2014
Rajesh KhoslaDirectorJun 2014